{"transactions":[{"id":4628021,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-29T11:00:11.000Z","date":"2026-09-25","kind":"purchase","planned":false,"acquired":true,"shares":2609,"price":6.28,"value":16384.52,"ownership":{"direct":true},"balance_after":47492,"source":{"system":"sec-edgar","filing":"0001628280-26-063766","document":"wk-form4_1790679609.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424383/000162828026063766/wk-form4_1790679609.xml","form_type":"4"}},{"id":692985,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-08-07T20:18:17.000Z","date":"2026-08-07","kind":"grant","planned":false,"acquired":true,"shares":43014,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents a grant of options to purchase ordinary shares. This grant of options was approved by the Board on May 7, 2026, subject to (i) approval by the Company's shareholders, which was obtained on July 14, 2026 and (ii) the filing by the Company of a Registration Statement on Form S-8 registering the ordinary shares underlying the option grant, which occurred on August 7, 2026. The options vest on a quarterly basis over a one-year period that began on February 4, 2026, subject to full acceleration upon a Change in Control (as defined in the Plan)."}],"balance_after":43014,"derivative":{"exercise_price":1.37,"expiration_date":"2036-05-07","underlying":"Ordinary Shares, par value NIS 0.0000769 per share","underlying_shares":43014},"source":{"system":"sec-edgar","filing":"0001178913-26-003949","document":"zk2635791.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1424383/000117891326003949/zk2635791.xml","form_type":"4"}},{"id":692984,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-08-07T20:18:17.000Z","date":"2026-08-07","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents a grant of options to purchase ordinary shares. This grant of options was approved by the Board on May 7, 2026, subject to (i) approval by the Company's shareholders, which was obtained on July 14, 2026 and (ii) the filing by the Company of a Registration Statement on Form S-8 registering the ordinary shares underlying the option grant, which occurred on August 7, 2026. The options vest over a three year period which began on February 4, 2026, with one-third of the options vesting on February 4, 2027 and the remaining two-thirds vesting ratably on a quarterly basis over the remaining two-year period, subject to full acceleration upon a Change in Control (as defined in the Company's 2018 Equity Incentive Plan (the \"Plan\"))."}],"balance_after":50000,"derivative":{"exercise_price":1.37,"expiration_date":"2036-05-07","underlying":"Ordinary Shares, par value NIS 0.0000769 per share","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001178913-26-003949","document":"zk2635791.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1424383/000117891326003949/zk2635791.xml","form_type":"4"}},{"id":692983,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value NIS 0.0000769 per share","published_at":"2026-08-07T20:18:17.000Z","date":"2026-08-07","kind":"grant","planned":false,"acquired":true,"shares":25014,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Board of Directors (the \"Board\") of Entera Bio Ltd. (the \"Company\") awarded these shares to the Reporting Person in lieu of the cash fees the Reporting Person was entitled to for services rendered as a director of the Company for the first quarter and second quarter of 2026. This grant of shares was approved by the Board on August 5, 2026, subject to the filing by the Company of a Registration Statement on Form S-8 registering the shares, which occurred on August 7, 2026."}],"balance_after":65014,"source":{"system":"sec-edgar","filing":"0001178913-26-003949","document":"zk2635791.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424383/000117891326003949/zk2635791.xml","form_type":"4"}},{"id":747782,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-05T11:37:20.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":20979,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest on the earlier to occur of (i) June 3, 2027 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest on the earlier to occur of (i) June 3, 2027 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date."}],"balance_after":20979,"derivative":{"underlying":"Common Stock","underlying_shares":20979},"source":{"system":"sec-edgar","filing":"0001628280-26-041041","document":"wk-form4_1780659437.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424383/000162828026041041/wk-form4_1780659437.xml","form_type":"4"}},{"id":765758,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-22T11:30:18.000Z","date":"2026-05-20","kind":"exercise","planned":false,"acquired":false,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 3, 2025 the Reporting person was granted RSUs. The RSUs vested on the earlier to occur of (i) June 3, 2026 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 3, 2025 the Reporting person was granted RSUs. The RSUs vested on the earlier to occur of (i) June 3, 2026 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0001628280-26-037533","document":"wk-form4_1779449415.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1424383/000162828026037533/wk-form4_1779449415.xml","form_type":"4"}},{"id":765757,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-22T11:30:18.000Z","date":"2026-05-20","kind":"exercise","planned":false,"acquired":true,"shares":21000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the vesting of Restricted Stock Units (\"RSUs\") on May 20, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":44883,"source":{"system":"sec-edgar","filing":"0001628280-26-037533","document":"wk-form4_1779449415.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424383/000162828026037533/wk-form4_1779449415.xml","form_type":"4"}},{"id":774809,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-05-19T01:51:38.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":21231,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in 36 equal monthly installments beginning on June 14, 2026."}],"balance_after":21231,"derivative":{"exercise_price":30.76,"expiration_date":"2036-05-14","underlying":"Common Stock","underlying_shares":21231},"source":{"system":"sec-edgar","filing":"0001424383-26-000003","document":"form4-05192026_010535.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424383/000142438326000003/form4-05192026_010535.xml","form_type":"4"}},{"id":848562,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value NIS 0.0000769 per share","published_at":"2026-03-11T12:30:10.000Z","date":"2026-03-09","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":1.3,"value":26000.0,"ownership":{"direct":true},"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001178913-26-000825","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424383/000117891326000825/ownership.xml","form_type":"4"}},{"id":909817,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value NIS 0.0000769 per share","published_at":"2026-02-11T13:45:55.000Z","date":"2026-02-10","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":1.49,"value":29800.0,"ownership":{"direct":true},"source":{"system":"sec-edgar","filing":"0001178913-26-000413","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424383/000117891326000413/ownership.xml","form_type":"4"}},{"id":964833,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-17T12:02:05.000Z","date":"2025-12-16","kind":"purchase","planned":false,"acquired":true,"shares":3000,"price":4.72,"value":14160.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.718 to $4.720. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote."}],"balance_after":23883,"source":{"system":"sec-edgar","filing":"0001628280-25-057485","document":"wk-form4_1765972922.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424383/000162828025057485/wk-form4_1765972922.xml","form_type":"4"}},{"id":1078338,"issuer":{"id":77038,"kind":"organization","name":"Sage Therapeutics, Inc.","symbol":"SAGE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-31T15:38:24.000Z","date":"2025-07-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":21500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of June 13, 2025, among Sage Therapeutics, Inc. (the \"Issuer\"), Supernus Pharmaceuticals, Inc. (\"Parent\"), and Saphire, Inc., a wholly owned subsidiary of Parent (\"Purchaser\"), pursuant to which Purchaser completed a cash tender offer to purchase all outstanding shares of common stock of the Issuer (each, a \"Share\") for (i) $8.50 per Share in cash (the \"Closing Amount\"), plus (ii) one contingent value right (\"CVR\") per Share, each without interest and subject to the withholding of applicable taxes, and thereafter merged with and into the Issuer, effective as of July 31, 2025 (the effective time of the merger, the \"Effective Time\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from footnote 1) Each CVR represents the right to receive up to $3.50 per Share in cash upon the satisfaction of specified milestones, as described in the Form 8-K filed by the Issuer with the Securities and Exchange Commission on June 16, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase Shares (a \"Company Option\") then outstanding and unexercised, whether or not vested, which had a per Share exercise price less than the Closing Amount was deemed fully vested and cancelled and converted into the right to receive (i) a cash payment (without interest and subject to the withholding of applicable taxes) equal to the product of (a) the excess of the Closing Amount over the per Share exercise price of such Company Option, multiplied by (b) the total number of Shares subject to such Company Option immediately prior to the Effective Time, plus (ii) one CVR for each Share subject to such Company Option immediately prior to the Effective Time. Each Company Option, whether or not vested, which had a per Share exercise price greater than or equal to the Closing Amount was cancelled with no consideration payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase Shares (a \"Company Option\") then outstanding and unexercised, whether or not vested, which had a per Share exercise price less than the Closing Amount was deemed fully vested and cancelled and converted into the right to receive (i) a cash payment (without interest and subject to the withholding of applicable taxes) equal to the product of (a) the excess of the Closing Amount over the per Share exercise price of such Company Option, multiplied by (b) the total number of Shares subject to such Company Option immediately prior to the Effective Time, plus (ii) one CVR for each Share subject to such Company Option immediately prior to the Effective Time. Each Company Option, whether or not vested, which had a per Share exercise price greater than or equal to the Closing Amount was cancelled with no consideration payable in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":6.77,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":21500},"source":{"system":"sec-edgar","filing":"0000950170-25-100663","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424383/000095017025100663/ownership.xml","form_type":"4"}},{"id":1111425,"issuer":{"id":77038,"kind":"organization","name":"Sage Therapeutics, Inc.","symbol":"SAGE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T20:14:14.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":21500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option award was issued pursuant to the Sage Therapeutics, Inc. 2024 Equity Incentive Plan in accordance with Sage's Non-Employee Director Compensation Program. The option will vest in full upon the earlier to occur of June 11, 2026 or the day immediately prior to the 2026 Annual Meeting of Sage's stockholders, subject to continued service as a director on such date."}],"balance_after":21500,"derivative":{"exercise_price":6.77,"expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":21500},"source":{"system":"sec-edgar","filing":"0001562180-25-004794","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424383/000156218025004794/primarydocument.xml","form_type":"4"}},{"id":1122729,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-04T21:01:02.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest on the earlier to occur of (i) June 3, 2026 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vest on the earlier to occur of (i) June 3, 2026 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date."}],"balance_after":21000,"derivative":{"underlying":"Common Stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0000950170-25-081728","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1424383/000095017025081728/ownership.xml","form_type":"4"}},{"id":1122728,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-04T21:01:02.000Z","date":"2025-05-27","kind":"exercise","planned":false,"acquired":false,"shares":9826,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 4, 2024 the Reporting person was granted RSUs. The RSUs vested on the earlier to occur of (i) June 4, 2025 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 4, 2024 the Reporting person was granted RSUs. The RSUs vested on the earlier to occur of (i) June 4, 2025 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":9826},"source":{"system":"sec-edgar","filing":"0000950170-25-081728","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1424383/000095017025081728/ownership.xml","form_type":"4"}},{"id":1122727,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-04T21:01:02.000Z","date":"2025-05-27","kind":"exercise","planned":false,"acquired":true,"shares":9826,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the vesting of Restricted Stock Units (\"RSUs\") on May 27, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":20883,"source":{"system":"sec-edgar","filing":"0000950170-25-081728","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424383/000095017025081728/ownership.xml","form_type":"4"}},{"id":1189666,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-27T11:00:04.000Z","date":"2025-03-25","kind":"purchase","planned":false,"acquired":true,"shares":3250,"price":5.3,"value":17225.0,"ownership":{"direct":true},"balance_after":11057,"source":{"system":"sec-edgar","filing":"0000950170-25-045720","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424383/000095017025045720/ownership.xml","form_type":"4"}},{"id":1318533,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-02T12:00:04.000Z","date":"2024-12-30","kind":"purchase","planned":false,"acquired":true,"shares":3605,"price":4.49,"value":16186.45,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.25 to $4.55. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote."}],"balance_after":7807,"source":{"system":"sec-edgar","filing":"0000950170-25-000071","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424383/000095017025000071/ownership.xml","form_type":"4"}},{"id":1483315,"issuer":{"id":77038,"kind":"organization","name":"Sage Therapeutics, Inc.","symbol":"SAGE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-11T20:58:24.000Z","date":"2024-06-10","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option award was issued pursuant to the Sage Therapeutics, Inc. 2024 Equity Incentive Plan in accordance with Sage's Non-Employee Director Compensation Program. The option will vest in full upon the earlier to occur of June 10, 2025 or the day immediately prior to the 2025 Annual Meeting of Sage's stockholders, subject to continued service as a director on such date."}],"balance_after":12500,"derivative":{"exercise_price":10.9,"expiration_date":"2034-06-09","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001562180-24-004951","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424383/000156218024004951/primarydocument.xml","form_type":"4"}},{"id":1488276,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-06-06T20:37:02.000Z","date":"2024-06-04","kind":"grant","planned":false,"acquired":true,"shares":9826,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest on the earlier to occur of (i) June 4, 2025 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest on the earlier to occur of (i) June 4, 2025 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date."}],"balance_after":9826,"derivative":{"underlying":"Common Stock","underlying_shares":9826},"source":{"system":"sec-edgar","filing":"0000950170-24-069938","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424383/000095017024069938/ownership.xml","form_type":"4"}},{"id":1524591,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-07T20:25:30.000Z","date":"2024-05-04","kind":"exercise","planned":false,"acquired":false,"shares":4202,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On May 4, 2023 the Reporting Person was granted RSUs. The RSUs vested in full on May 4, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On May 4, 2023 the Reporting Person was granted RSUs. The RSUs vested in full on May 4, 2024."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4202},"source":{"system":"sec-edgar","filing":"0000950170-24-054581","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1424383/000095017024054581/ownership.xml","form_type":"4"}},{"id":1524590,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-07T20:25:30.000Z","date":"2024-05-04","kind":"exercise","planned":false,"acquired":true,"shares":4202,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the vesting and settlement of Restricted Stock Units (\"RSUs\") on May 4, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"On February 13, 2024, the Issuer effected a 1-for-30 reverse stock split. The amounts of securities herein have been adjusted to reflect the reverse stock split."}],"balance_after":4202,"source":{"system":"sec-edgar","filing":"0000950170-24-054581","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424383/000095017024054581/ownership.xml","form_type":"4"}},{"id":1851939,"issuer":{"id":77038,"kind":"organization","name":"Sage Therapeutics, Inc.","symbol":"SAGE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T20:06:01.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option award was issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan in accordance with the terms of the Amended and Restated Non-Employee Director Compensation Policy. The option will vest in full upon the earlier to occur of June 15, 2024 or the day immediately prior to the 2024 Annual Meeting of Sage's stockholders, subject to continued service as a director on such date."}],"balance_after":10000,"derivative":{"exercise_price":56.1,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001562180-23-005262","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424383/000156218023005262/primarydocument.xml","form_type":"4"}},{"id":1900829,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-05-08T20:15:09.000Z","date":"2023-05-04","kind":"grant","planned":false,"acquired":true,"shares":126075,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest on the earlier to occur of (i) May 4, 2024 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest on the earlier to occur of (i) May 4, 2024 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date."}],"balance_after":126075,"derivative":{"underlying":"Common Stock","underlying_shares":126075},"source":{"system":"sec-edgar","filing":"0001209191-23-027922","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424383/000120919123027922/doc4.xml","form_type":"4"}},{"id":2227498,"issuer":{"id":77038,"kind":"organization","name":"Sage Therapeutics, Inc.","symbol":"SAGE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-17T20:35:38.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":9947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option award was issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan in accordance with the terms of the Amended and Restated Non-Employee Director Compensation Policy. The option will vest in full upon the earlier to occur of June 16, 2023 or the day immediately prior to the 2023 Annual Meeting of Sage's stockholders, subject to continued service as a director on such date."}],"balance_after":9947,"derivative":{"exercise_price":31.36,"expiration_date":"2032-06-16","underlying":"Common Stock","underlying_shares":9947},"source":{"system":"sec-edgar","filing":"0001562180-22-005203","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424383/000156218022005203/primarydocument.xml","form_type":"4"}},{"id":2273388,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-12T11:15:52.000Z","date":"2022-05-10","kind":"grant","acquired":true,"shares":156951,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier to occur of (i) May 10, 2023 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date."}],"balance_after":156951,"derivative":{"exercise_price":1.86,"expiration_date":"2032-05-09","underlying":"Common Stock","underlying_shares":156951},"source":{"system":"sec-edgar","filing":"0001209191-22-028449","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424383/000120919122028449/doc4.xml","form_type":"4"}},{"id":2671736,"issuer":{"id":77038,"kind":"organization","name":"Sage Therapeutics, Inc.","symbol":"SAGE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-11T20:09:08.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option award was issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan in accordance with the terms of the Amended and Restated Non-Employee Director Compensation Policy. The option will vest in full upon the earlier to occur of June 10, 2022 or the day immediately prior to the 2022 Annual Meeting of Sage's stockholders, subject to continued service as a director on such date."}],"balance_after":10000,"derivative":{"exercise_price":76.09,"expiration_date":"2031-06-10","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001562180-21-004206","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424383/000156218021004206/primarydocument.xml","form_type":"4"}},{"id":2716241,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-12T20:03:57.000Z","date":"2021-05-10","kind":"grant","acquired":true,"shares":32800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of May 10, 2022 or the day immediately prior to the date of the next annual meeting of the Company's stockholders occurring after May 10, 2021, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date."}],"balance_after":32800,"derivative":{"exercise_price":8.07,"expiration_date":"2031-05-09","underlying":"Common Stock","underlying_shares":32800},"source":{"system":"sec-edgar","filing":"0001209191-21-032013","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424383/000120919121032013/doc4.xml","form_type":"4"}},{"id":3113270,"issuer":{"id":77038,"kind":"organization","name":"Sage Therapeutics, Inc.","symbol":"SAGE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-11T20:18:25.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option award was issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan in accordance with the terms of the Amended and Restated Non-Employee Director Compensation Policy. The option will vest in full upon the earlier to occur of June 9, 2021 or the day immediately prior to the 2021 Annual Meeting of Sage's stockholders, subject to continued service as a director on such date."}],"balance_after":10000,"derivative":{"exercise_price":36.47,"expiration_date":"2030-06-09","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001562180-20-004428","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424383/000156218020004428/primarydocument.xml","form_type":"4"}},{"id":3213385,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right To Buy)","published_at":"2020-03-12T20:36:39.000Z","date":"2020-03-10","kind":"grant","acquired":true,"shares":71776,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over 3 years in 36 substantially equal monthly installments following March 10, 2020."}],"balance_after":71776,"derivative":{"exercise_price":7.57,"expiration_date":"2030-03-09","underlying":"Common Stock","underlying_shares":71776},"source":{"system":"sec-edgar","filing":"0001209191-20-018527","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424383/000120919120018527/doc4.xml","form_type":"4"}},{"id":3319042,"issuer":{"id":152552,"kind":"organization","name":"MEDICINES CO /DE","symbol":"MDCO"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2020-01-06T13:26:09.000Z","date":"2020-01-06","kind":"disposition_to_issuer","acquired":false,"shares":8410,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By grantor retained annuity trust"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, each option (each an \"Option\") that was outstanding immediately prior to the consummation of the tender offer by Parent and Purchaser, whether vested or unvested, became fully vested and was canceled as of immediately prior to, and contingent upon, the effective time of the Merger, in exchange for the right to receive an amount in cash equal to the product of (x) the excess (if any) of the Offer Price over the per share exercise price payable in respect of each Share issuable under such Option, multiplied by (y) the number of Shares issuable under such Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, each option (each an \"Option\") that was outstanding immediately prior to the consummation of the tender offer by Parent and Purchaser, whether vested or unvested, became fully vested and was canceled as of immediately prior to, and contingent upon, the effective time of the Merger, in exchange for the right to receive an amount in cash equal to the product of (x) the excess (if any) of the Offer Price over the per share exercise price payable in respect of each Share issuable under such Option, multiplied by (y) the number of Shares issuable under such Option."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"In August 2019, the Reporting Person contributed the Options to a grantor retained\nannuity trust with his children as beneficiaries."}],"balance_after":0,"derivative":{"exercise_price":34.81,"underlying":"Common Stock","underlying_shares":8410},"source":{"system":"sec-edgar","filing":"0000950142-20-000043","document":"es2000128_4-germano.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1113481/000095014220000043/es2000128_4-germano.xml","form_type":"4"}},{"id":3319041,"issuer":{"id":152552,"kind":"organization","name":"MEDICINES CO /DE","symbol":"MDCO"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2020-01-06T13:26:09.000Z","date":"2020-01-06","kind":"disposition_to_issuer","acquired":false,"shares":9141,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By grantor retained annuity trust"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, each option (each an \"Option\") that was outstanding immediately prior to the consummation of the tender offer by Parent and Purchaser, whether vested or unvested, became fully vested and was canceled as of immediately prior to, and contingent upon, the effective time of the Merger, in exchange for the right to receive an amount in cash equal to the product of (x) the excess (if any) of the Offer Price over the per share exercise price payable in respect of each Share issuable under such Option, multiplied by (y) the number of Shares issuable under such Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, each option (each an \"Option\") that was outstanding immediately prior to the consummation of the tender offer by Parent and Purchaser, whether vested or unvested, became fully vested and was canceled as of immediately prior to, and contingent upon, the effective time of the Merger, in exchange for the right to receive an amount in cash equal to the product of (x) the excess (if any) of the Offer Price over the per share exercise price payable in respect of each Share issuable under such Option, multiplied by (y) the number of Shares issuable under such Option."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"In August 2019, the Reporting Person contributed the Options to a grantor retained\nannuity trust with his children as beneficiaries."}],"balance_after":0,"derivative":{"exercise_price":33.86,"underlying":"Common Stock","underlying_shares":9141},"source":{"system":"sec-edgar","filing":"0000950142-20-000043","document":"es2000128_4-germano.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1113481/000095014220000043/es2000128_4-germano.xml","form_type":"4"}},{"id":3319040,"issuer":{"id":152552,"kind":"organization","name":"MEDICINES CO /DE","symbol":"MDCO"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2020-01-06T13:26:09.000Z","date":"2020-01-06","kind":"disposition_to_issuer","acquired":false,"shares":27243,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By grantor retained annuity trust"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, each option (each an \"Option\") that was outstanding immediately prior to the consummation of the tender offer by Parent and Purchaser, whether vested or unvested, became fully vested and was canceled as of immediately prior to, and contingent upon, the effective time of the Merger, in exchange for the right to receive an amount in cash equal to the product of (x) the excess (if any) of the Offer Price over the per share exercise price payable in respect of each Share issuable under such Option, multiplied by (y) the number of Shares issuable under such Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, each option (each an \"Option\") that was outstanding immediately prior to the consummation of the tender offer by Parent and Purchaser, whether vested or unvested, became fully vested and was canceled as of immediately prior to, and contingent upon, the effective time of the Merger, in exchange for the right to receive an amount in cash equal to the product of (x) the excess (if any) of the Offer Price over the per share exercise price payable in respect of each Share issuable under such Option, multiplied by (y) the number of Shares issuable under such Option."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"In August 2019, the Reporting Person contributed the Options to a grantor retained\nannuity trust with his children as beneficiaries."}],"balance_after":0,"derivative":{"exercise_price":30.9,"underlying":"Common Stock","underlying_shares":27243},"source":{"system":"sec-edgar","filing":"0000950142-20-000043","document":"es2000128_4-germano.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1113481/000095014220000043/es2000128_4-germano.xml","form_type":"4"}},{"id":3319039,"issuer":{"id":152552,"kind":"organization","name":"MEDICINES CO /DE","symbol":"MDCO"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-06T13:26:09.000Z","date":"2020-01-06","kind":"disposition_to_issuer","acquired":false,"shares":7429,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of November 23, 2019 (the \"Merger Agreement\"), by and among the Company, Novartis AG (\"Parent\") and Medusa Merger Corporation (\"Purchaser\"), on January 6, 2020, Purchaser was merged with and into the Company (the \"Merger\"), with the Company surviving the Merger as an indirect wholly-owned subsidiary of Parent. Pursuant to the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.001 per share, of the Company (each a \"Share\") was converted into the right to receive $85.00 per Share, net to the seller in cash (the \"Offer Price\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The number of Shares reported includes 3,663 unvested restricted Shares (each a \"Restricted Share\"). Each Restricted Share that was outstanding immediately prior to the consummation of the tender offer by Parent and Purchaser automatically became fully vested as of immediately prior to, and contingent upon, the effective time of the Merger and was treated in the same manner as an outstanding Share."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950142-20-000043","document":"es2000128_4-germano.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1113481/000095014220000043/es2000128_4-germano.xml","form_type":"4"}},{"id":3498751,"issuer":{"id":77038,"kind":"organization","name":"Sage Therapeutics, Inc.","symbol":"SAGE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-06T20:02:32.000Z","date":"2019-06-05","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option award was issued pursuant to the Sage Therapeutics, Inc., 2014 Stock Option and Incentive Plan in accordance with the terms of the Amended and Restated Non-Employee Director Compensation Policy. The option will vest in full upon the earlier to occur of June 5, 2020 or the day immediately prior to the 2020 Annual Meeting of Sage's stockholders, subject to continued service as a director on such date."}],"balance_after":10000,"derivative":{"exercise_price":177.41,"expiration_date":"2029-06-05","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001562180-19-003392","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424383/000156218019003392/primarydocument.xml","form_type":"4"}},{"id":3505112,"issuer":{"id":152552,"kind":"organization","name":"MEDICINES CO /DE","symbol":"MDCO"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right-to-buy)","published_at":"2019-06-03T17:23:20.000Z","date":"2019-05-30","kind":"grant","acquired":true,"shares":8410,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in one installment on May 30, 2020 and was made as part of and pursuant to the Issuer's director compensation program."}],"balance_after":8410,"derivative":{"exercise_price":34.81,"expiration_date":"2029-05-30","underlying":"Common Stock","underlying_shares":8410},"source":{"system":"sec-edgar","filing":"0001179110-19-007034","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1113481/000117911019007034/edgar.xml","form_type":"4"}},{"id":3505111,"issuer":{"id":152552,"kind":"organization","name":"MEDICINES CO /DE","symbol":"MDCO"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-03T17:23:20.000Z","date":"2019-05-30","kind":"grant","acquired":true,"shares":3663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock award vests on May 30, 2020 and was made as part of and pursuant to the Issuer's director compensation program."}],"balance_after":7429,"source":{"system":"sec-edgar","filing":"0001179110-19-007034","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1113481/000117911019007034/edgar.xml","form_type":"4"}},{"id":3703818,"issuer":{"id":77038,"kind":"organization","name":"Sage Therapeutics, Inc.","symbol":"SAGE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-04T21:01:15.000Z","date":"2019-01-03","kind":"grant","acquired":true,"shares":878,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person elected to receive this stock option award in lieu of payment of all cash retainers that would otherwise be paid for his service during 2019 on the issuer's board or its committees, as permitted under the issuer's amended and restated non-employee director compensation policy. The stock option is granted under and subject to the terms of the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. The option will vest in full on December 31, 2019, subject to the reporting person's continued service through such date."}],"balance_after":878,"derivative":{"exercise_price":89.33,"expiration_date":"2029-01-03","underlying":"Common Stock","underlying_shares":878},"source":{"system":"sec-edgar","filing":"0001562180-19-000187","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424383/000156218019000187/primarydocument.xml","form_type":"4"}},{"id":3899905,"issuer":{"id":77038,"kind":"organization","name":"Sage Therapeutics, Inc.","symbol":"SAGE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-08T20:03:42.000Z","date":"2018-06-06","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option award was issued pursuant to the Sage Therapeutics, Inc., 2014 Stock Option and Incentive Plan. The option will vest in full upon the earlier to occur of June 6, 2019 or the day immediately prior to the 2019 Annual Meeting of Sage's stockholders, subject to continued service as a director on such date."}],"balance_after":10000,"derivative":{"exercise_price":154.06,"expiration_date":"2028-06-06","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001562180-18-002928","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424383/000156218018002928/primarydocument.xml","form_type":"4"}},{"id":3908849,"issuer":{"id":152552,"kind":"organization","name":"MEDICINES CO /DE","symbol":"MDCO"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right-to-buy)","published_at":"2018-06-04T16:52:14.000Z","date":"2018-05-31","kind":"grant","acquired":true,"shares":9141,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in one installment on May 31, 2019 and was made as part of and pursuant to the Issuer's director compensation program."}],"balance_after":9141,"derivative":{"exercise_price":33.86,"expiration_date":"2028-05-31","underlying":"Common Stock","underlying_shares":9141},"source":{"system":"sec-edgar","filing":"0001179110-18-007955","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1113481/000117911018007955/edgar.xml","form_type":"4"}},{"id":3908848,"issuer":{"id":152552,"kind":"organization","name":"MEDICINES CO /DE","symbol":"MDCO"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-04T16:52:14.000Z","date":"2018-05-31","kind":"grant","acquired":true,"shares":3766,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock award vests on May 31, 2019 and was made as part of and pursuant to the Issuer's director compensation program."}],"balance_after":3766,"source":{"system":"sec-edgar","filing":"0001179110-18-007955","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1113481/000117911018007955/edgar.xml","form_type":"4"}},{"id":4005253,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":true}}],"security":"Non-Qualified Stock Option","published_at":"2018-03-08T17:27:18.000Z","date":"2018-03-08","kind":"disposition_to_issuer","acquired":false,"shares":21729,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the Offer, whether vested or unvested, automatically  became fully vested and was cancelled as of immediately prior to, and contingent upon, the consummation of the Offer in exchange for the right to receive a lump-sum cash payment in the amount of the Option Consideration, if any, less any required withholding taxes, with respect to such Option. \"Option Consideration\" means, with respect to any Option, an amount equal to the product of (i) the number of Shares issuable under such Option multiplied by (ii) the excess of (x) $105.00 over (y) the exercise price payable in respect of each Share issuable under such Option."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the Offer, whether vested or unvested, automatically  became fully vested and was cancelled as of immediately prior to, and contingent upon, the consummation of the Offer in exchange for the right to receive a lump-sum cash payment in the amount of the Option Consideration, if any, less any required withholding taxes, with respect to such Option. \"Option Consideration\" means, with respect to any Option, an amount equal to the product of (i) the number of Shares issuable under such Option multiplied by (ii) the excess of (x) $105.00 over (y) the exercise price payable in respect of each Share issuable under such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the Offer, whether vested or unvested, automatically  became fully vested and was cancelled as of immediately prior to, and contingent upon, the consummation of the Offer in exchange for the right to receive a lump-sum cash payment in the amount of the Option Consideration, if any, less any required withholding taxes, with respect to such Option. \"Option Consideration\" means, with respect to any Option, an amount equal to the product of (i) the number of Shares issuable under such Option multiplied by (ii) the excess of (x) $105.00 over (y) the exercise price payable in respect of each Share issuable under such Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the Offer, whether vested or unvested, automatically  became fully vested and was cancelled as of immediately prior to, and contingent upon, the consummation of the Offer in exchange for the right to receive a lump-sum cash payment in the amount of the Option Consideration, if any, less any required withholding taxes, with respect to such Option. \"Option Consideration\" means, with respect to any Option, an amount equal to the product of (i) the number of Shares issuable under such Option multiplied by (ii) the excess of (x) $105.00 over (y) the exercise price payable in respect of each Share issuable under such Option."}],"balance_after":0,"derivative":{"exercise_price":55.04,"underlying":"Common Stock","underlying_shares":21729},"source":{"system":"sec-edgar","filing":"0001127602-18-010662","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1424383/000112760218010662/form4.xml","form_type":"4"}},{"id":4005252,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2018-03-08T17:27:18.000Z","date":"2018-03-08","kind":"disposition_to_issuer","acquired":false,"shares":5455,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated as of January 21, 2018 (the \"Merger Agreement\"), between the Company, Sanofi, a French soci?t? anonyme (the \"Parent\"), and Blink Acquisition Corp. (\"Merger Sub\"), on March 8, 2018, Merger Sub was merged with and into the Company, with the Company continuing as the surviving corporation and a wholly owned subsidiary of Parent (the \"Merger\")."},{"field":"shares","element":"transactionShares","label":"F3","text":"Pursuant to the Merger Agreement, each RSU outstanding immediately prior to the consummation of the tender offer by Parent and Merger Sub to acquire all the outstanding Shares for $105.00 in cash (the \"Offer\") automatically and without any required action on the part of its holder became fully vested and was converted immediately prior to, and contingent upon, the consummation of the Offer into a vested right to receive a lump-sum payment in an amount equal to $105.00 for each Share underlying the RSU, less any required withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, each RSU outstanding immediately prior to the consummation of the tender offer by Parent and Merger Sub to acquire all the outstanding Shares for $105.00 in cash (the \"Offer\") automatically and without any required action on the part of its holder became fully vested and was converted immediately prior to, and contingent upon, the consummation of the Offer into a vested right to receive a lump-sum payment in an amount equal to $105.00 for each Share underlying the RSU, less any required withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, each RSU outstanding immediately prior to the consummation of the tender offer by Parent and Merger Sub to acquire all the outstanding Shares for $105.00 in cash (the \"Offer\") automatically and without any required action on the part of its holder became fully vested and was converted immediately prior to, and contingent upon, the consummation of the Offer into a vested right to receive a lump-sum payment in an amount equal to $105.00 for each Share underlying the RSU, less any required withholding taxes."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, each RSU outstanding immediately prior to the consummation of the tender offer by Parent and Merger Sub to acquire all the outstanding Shares for $105.00 in cash (the \"Offer\") automatically and without any required action on the part of its holder became fully vested and was converted immediately prior to, and contingent upon, the consummation of the Offer into a vested right to receive a lump-sum payment in an amount equal to $105.00 for each Share underlying the RSU, less any required withholding taxes."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5455},"source":{"system":"sec-edgar","filing":"0001127602-18-010662","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424383/000112760218010662/form4.xml","form_type":"4"}},{"id":4079053,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2018-02-02T22:14:05.000Z","date":"2018-01-31","kind":"grant","acquired":true,"shares":5455,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in full on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in full on the first anniversary of the date of grant."}],"balance_after":5455,"derivative":{"underlying":"Common Stock","underlying_shares":5455},"source":{"system":"sec-edgar","filing":"0001127602-18-003809","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424383/000112760218003809/form4.xml","form_type":"4"}},{"id":4156778,"issuer":{"id":152552,"kind":"organization","name":"MEDICINES CO /DE","symbol":"MDCO"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Call Option (right-to-buy)","published_at":"2017-11-20T17:24:24.000Z","date":"2017-11-09","kind":"grant","acquired":true,"shares":27243,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in one installment on November 9, 2020 and is made part of and pursuant to Issuer's director compensation package."}],"balance_after":27243,"derivative":{"exercise_price":30.9,"expiration_date":"2027-11-09","underlying":"Common Stock","underlying_shares":27243},"source":{"system":"sec-edgar","filing":"0001179110-17-014381","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1113481/000117911017014381/edgar.xml","form_type":"4"}},{"id":4288302,"issuer":{"id":77038,"kind":"organization","name":"Sage Therapeutics, Inc.","symbol":"SAGE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-08T23:38:23.000Z","date":"2017-06-07","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option award was issued pursuant to the Sage Therapeutics, Inc., 2014 Stock Option and Incentive Plan. The option will vest in full upon the earlier to occur of June 7, 2018 or the day immediately prior to the 2018 Annual Meeting of Sage's stockholders, subject to continued service as a director on such date."}],"balance_after":14000,"derivative":{"exercise_price":72.74,"expiration_date":"2027-06-07","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001562180-17-002239","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424383/000156218017002239/primarydocument.xml","form_type":"4"}},{"id":4320859,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":true}}],"security":"Non-Qualified Stock Option","published_at":"2017-05-15T21:02:06.000Z","date":"2017-05-11","kind":"grant","acquired":true,"shares":21729,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in three equal annual installments beginning on May 11, 2018."}],"balance_after":21729,"derivative":{"exercise_price":55.04,"expiration_date":"2027-05-11","underlying":"Common Stock","underlying_shares":21729},"source":{"system":"sec-edgar","filing":"0001127602-17-018094","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424383/000112760217018094/form4.xml","form_type":"4"}},{"id":4595028,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Option to Purchase Common Stock (Right to Buy)","published_at":"2016-09-26T22:29:19.000Z","date":"2016-09-22","kind":"grant","acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award represents the Issuer's remaining obligation to grant the reporting person option awards for 2,000,000 shares.  A Form 4 dated June 3, 2016 reported that the reporting person previously received an option for 2,000,000 shares.  That Form 4 has subsequently been amended to reflect that the initial grant was only effective with respect to 1,000,000 shares.  This Form 4 reports that the reporting person has now received an option for the remaining 1,000,000 shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options vest in 25% increments on June 1, 2017, 2018, 2019 and 2020."}],"balance_after":1000000,"derivative":{"exercise_price":29.94,"expiration_date":"2026-05-31","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001225385-16-000081","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424383/000122538516000081/edgar.xml","form_type":"4"}},{"id":4595029,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Option to Purchase Common Stock (Right to Buy)","published_at":"2016-09-26T22:28:00.000Z","date":"2016-06-01","kind":"grant","acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The original Form 4 filed on June 3, 2016 previously reported a grant of an option for 2,000,000 shares in connection with the reporting person's appointment as President of the Issuer.  However, the option grant was only effective with respect to 1,000,000 shares, and this report is being filed to correct the prior over-reporting of the grant.  On September 22, 2016, the reporting person was granted an option with respect to the remaining 1,000,000 option shares to which he was entitled. Those options are being reported on a separate Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options vest in 25% increments on June 1, 2017, 2018, 2019 and 2020."}],"balance_after":1000000,"derivative":{"exercise_price":29.94,"expiration_date":"2026-06-01","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001225385-16-000080","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1424383/000122538516000080/edgar.xml","form_type":"4/A","original_submission_date":"2016-06-03"}},{"id":454437,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Group President"}}],"security":"Stock Appreciation Rights","published_at":"2015-02-27T23:27:51.000Z","date":"2015-02-26","kind":"grant","acquired":true,"shares":120805,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant."}],"balance_after":120805,"derivative":{"exercise_price":34.59,"exercise_date":"2022-02-26","expiration_date":"2022-02-26","underlying":"Common Stock","underlying_shares":120805},"source":{"system":"sec-edgar","filing":"0001225208-15-006196","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520815006196/doc4.xml","form_type":"4"}},{"id":454436,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Group President"}}],"security":"Stock Appreciation Rights","published_at":"2015-02-27T23:27:51.000Z","date":"2015-02-26","kind":"grant","acquired":true,"shares":144928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant."}],"balance_after":144928,"derivative":{"exercise_price":34.59,"exercise_date":"2020-02-26","expiration_date":"2020-02-26","underlying":"Common Stock","underlying_shares":144928},"source":{"system":"sec-edgar","filing":"0001225208-15-006196","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520815006196/doc4.xml","form_type":"4"}},{"id":454435,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Group President"}}],"security":"Stock Appreciation Rights","published_at":"2015-02-27T23:27:51.000Z","date":"2015-02-25","kind":"exercise","acquired":false,"shares":83333,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":17.69,"exercise_date":"2015-02-25","expiration_date":"2015-02-25","underlying":"Common Stock","underlying_shares":83333},"source":{"system":"sec-edgar","filing":"0001225208-15-006196","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520815006196/doc4.xml","form_type":"4"}},{"id":454434,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Group President"}}],"security":"Common Stock","published_at":"2015-02-27T23:27:51.000Z","date":"2015-02-25","kind":"tax_withholding","acquired":false,"shares":32840,"price":33.47,"value":1099154.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon)."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used."}],"balance_after":308254,"source":{"system":"sec-edgar","filing":"0001225208-15-006196","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520815006196/doc4.xml","form_type":"4"}},{"id":454433,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Group President"}}],"security":"Common Stock","published_at":"2015-02-27T23:27:51.000Z","date":"2015-02-25","kind":"tax_withholding","acquired":false,"shares":24856,"price":34.66,"value":861508.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights."}],"balance_after":341094,"source":{"system":"sec-edgar","filing":"0001225208-15-006196","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520815006196/doc4.xml","form_type":"4"}},{"id":454432,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Group President"}}],"security":"Common Stock","published_at":"2015-02-27T23:27:51.000Z","date":"2015-02-25","kind":"tax_withholding","acquired":false,"shares":6474,"price":34.66,"value":224388.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon)."}],"balance_after":365950,"source":{"system":"sec-edgar","filing":"0001225208-15-006196","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520815006196/doc4.xml","form_type":"4"}},{"id":454431,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Group President"}}],"security":"Common Stock","published_at":"2015-02-27T23:27:51.000Z","date":"2015-02-25","kind":"grant","acquired":true,"shares":17893,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon)."}],"balance_after":372424,"source":{"system":"sec-edgar","filing":"0001225208-15-006196","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520815006196/doc4.xml","form_type":"4"}},{"id":454430,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Group President"}}],"security":"Common Stock","published_at":"2015-02-27T23:27:51.000Z","date":"2015-02-25","kind":"exercise","acquired":true,"shares":83333,"price":17.69,"value":1474160.77,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon)."}],"balance_after":354531,"source":{"system":"sec-edgar","filing":"0001225208-15-006196","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520815006196/doc4.xml","form_type":"4"}},{"id":457360,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Group President"}}],"security":"Phantom Stock Units SSP","published_at":"2015-01-15T19:12:12.000Z","date":"2015-01-13","kind":"grant","acquired":true,"shares":395,"price":32.44,"value":12813.8,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":11606,"derivative":{"underlying":"Common Stock","underlying_shares":395},"source":{"system":"sec-edgar","filing":"0001225208-15-001405","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520815001405/doc4.xml","form_type":"4"}},{"id":460679,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Group President"}}],"security":"Phantom Stock Units SSP","published_at":"2014-10-14T13:36:43.000Z","date":"2014-10-10","kind":"grant","acquired":true,"shares":446,"price":29.13,"value":12991.98,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":11131,"derivative":{"underlying":"Common Stock","underlying_shares":446},"source":{"system":"sec-edgar","filing":"0001225208-14-021568","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520814021568/doc4.xml","form_type":"4"}},{"id":463328,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Group President"}}],"security":"Phantom Stock Units SSP","published_at":"2014-07-15T17:30:45.000Z","date":"2014-07-11","kind":"grant","acquired":true,"shares":429,"price":30.07,"value":12900.03,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":10594,"derivative":{"underlying":"Common Stock","underlying_shares":429},"source":{"system":"sec-edgar","filing":"0001225208-14-016956","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520814016956/doc4.xml","form_type":"4"}},{"id":464340,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Group President"}}],"security":"Common Stock","published_at":"2014-06-04T14:17:06.000Z","date":"2014-06-02","kind":"sale","acquired":false,"shares":30000,"price":29.68,"value":890400.0,"ownership":{"direct":true},"balance_after":263495,"source":{"system":"sec-edgar","filing":"0001225208-14-014457","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520814014457/doc4.xml","form_type":"4"}},{"id":466187,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Group President"}}],"security":"Phantom Stock Units SSP","published_at":"2014-04-02T20:21:55.000Z","date":"2014-03-31","kind":"grant","acquired":true,"shares":63,"price":32.12,"value":2023.56,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":10075,"derivative":{"underlying":"Common Stock","underlying_shares":63},"source":{"system":"sec-edgar","filing":"0001225208-14-009704","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520814009704/doc4.xml","form_type":"4"}},{"id":466640,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Group President"}}],"security":"Phantom Stock Units SSP","published_at":"2014-03-18T13:33:09.000Z","date":"2014-03-14","kind":"grant","acquired":true,"shares":1520,"price":31.23,"value":47469.6,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":10012,"derivative":{"underlying":"Common Stock","underlying_shares":1520},"source":{"system":"sec-edgar","filing":"0001225208-14-008426","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520814008426/doc4.xml","form_type":"4"}},{"id":467667,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Group President"}}],"security":"Common Stock","published_at":"2014-03-04T14:07:34.000Z","date":"2014-02-26","kind":"tax_withholding","acquired":false,"shares":19668,"price":31.99,"value":629179.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon)."}],"balance_after":264320,"source":{"system":"sec-edgar","filing":"0001225208-14-007149","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520814007149/doc4a.xml","form_type":"4/A","original_submission_date":"2014-02-28"}},{"id":467910,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Group President"}}],"security":"Stock Appreciation Rights","published_at":"2014-02-28T21:52:22.000Z","date":"2014-02-27","kind":"grant","acquired":true,"shares":122951,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant."}],"balance_after":122951,"derivative":{"exercise_price":32.23,"exercise_date":"2021-02-27","expiration_date":"2021-02-27","underlying":"Common Stock","underlying_shares":122951},"source":{"system":"sec-edgar","filing":"0001225208-14-006889","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520814006889/doc4.xml","form_type":"4"}},{"id":467909,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Group President"}}],"security":"Stock Appreciation Rights","published_at":"2014-02-28T21:52:22.000Z","date":"2014-02-27","kind":"grant","acquired":true,"shares":154374,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant."}],"balance_after":154374,"derivative":{"exercise_price":32.23,"exercise_date":"2019-02-27","expiration_date":"2019-02-27","underlying":"Common Stock","underlying_shares":154374},"source":{"system":"sec-edgar","filing":"0001225208-14-006889","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520814006889/doc4.xml","form_type":"4"}},{"id":467908,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Group President"}}],"security":"Common Stock","published_at":"2014-02-28T21:52:22.000Z","date":"2014-02-27","kind":"grant","acquired":true,"shares":28134,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements."}],"balance_after":291834,"source":{"system":"sec-edgar","filing":"0001225208-14-006889","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520814006889/doc4.xml","form_type":"4"}},{"id":467907,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Group President"}}],"security":"Common Stock","published_at":"2014-02-28T21:52:22.000Z","date":"2014-02-26","kind":"tax_withholding","acquired":false,"shares":20288,"price":31.99,"value":649013.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon)."}],"balance_after":263700,"source":{"system":"sec-edgar","filing":"0001225208-14-006889","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520814006889/doc4.xml","form_type":"4"}},{"id":467906,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Group President"}}],"security":"Common Stock","published_at":"2014-02-28T21:52:22.000Z","date":"2014-02-26","kind":"grant","acquired":true,"shares":50231,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon)."}],"balance_after":283988,"source":{"system":"sec-edgar","filing":"0001225208-14-006889","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520814006889/doc4.xml","form_type":"4"}},{"id":470976,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Business Unit President"}}],"security":"Phantom Stock Units SSP","published_at":"2014-01-03T01:35:49.000Z","date":"2013-12-31","kind":"grant","acquired":true,"shares":56,"price":30.63,"value":1715.28,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":8431,"derivative":{"underlying":"Common Stock","underlying_shares":56},"source":{"system":"sec-edgar","filing":"0001225208-14-000195","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520814000195/doc4.xml","form_type":"4"}},{"id":471303,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Business Unit President"}}],"security":"Phantom Stock Units SSP","published_at":"2013-12-16T21:41:10.000Z","date":"2013-12-13","kind":"grant","acquired":true,"shares":60,"price":30.25,"value":1815.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":8375,"derivative":{"underlying":"Common Stock","underlying_shares":60},"source":{"system":"sec-edgar","filing":"0001225208-13-025447","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520813025447/doc4.xml","form_type":"4"}},{"id":471812,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Business Unit President"}}],"security":"Phantom Stock Units SSP","published_at":"2013-12-02T18:17:16.000Z","date":"2013-11-27","kind":"grant","acquired":true,"shares":55,"price":31.88,"value":1753.4,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":8315,"derivative":{"underlying":"Common Stock","underlying_shares":55},"source":{"system":"sec-edgar","filing":"0001225208-13-024406","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520813024406/doc4.xml","form_type":"4"}},{"id":472525,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Business Unit President"}}],"security":"Phantom Stock Units SSP","published_at":"2013-11-18T20:31:49.000Z","date":"2013-11-15","kind":"grant","acquired":true,"shares":168,"price":32,"value":5376.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":8311,"derivative":{"underlying":"Common Stock","underlying_shares":168},"source":{"system":"sec-edgar","filing":"0001225208-13-023744","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520813023744/doc4.xml","form_type":"4"}},{"id":473162,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Business Unit President"}}],"security":"Phantom Stock Units SSP","published_at":"2013-11-04T20:55:51.000Z","date":"2013-10-31","kind":"grant","acquired":true,"shares":49,"price":30.69,"value":1503.81,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":8143,"derivative":{"underlying":"Common Stock","underlying_shares":49},"source":{"system":"sec-edgar","filing":"0001225208-13-022780","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520813022780/doc4.xml","form_type":"4"}},{"id":473616,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Business Unit President"}}],"security":"Phantom Stock Units SSP","published_at":"2013-10-16T19:02:26.000Z","date":"2013-10-15","kind":"grant","acquired":true,"shares":64,"price":29.16,"value":1866.24,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":8094,"derivative":{"underlying":"Common Stock","underlying_shares":64},"source":{"system":"sec-edgar","filing":"0001225208-13-021908","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520813021908/doc4.xml","form_type":"4"}},{"id":473887,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Business Unit President"}}],"security":"Phantom Stock Units SSP","published_at":"2013-10-02T14:01:55.000Z","date":"2013-09-30","kind":"grant","acquired":true,"shares":54,"price":28.73,"value":1551.42,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":8030,"derivative":{"underlying":"Common Stock","underlying_shares":54},"source":{"system":"sec-edgar","filing":"0001225208-13-020977","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520813020977/doc4.xml","form_type":"4"}},{"id":474273,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Business Unit President"}}],"security":"Phantom Stock Units SSP","published_at":"2013-09-17T16:55:28.000Z","date":"2013-09-13","kind":"grant","acquired":true,"shares":61,"price":28.51,"value":1739.11,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":7976,"derivative":{"underlying":"Common Stock","underlying_shares":61},"source":{"system":"sec-edgar","filing":"0001225208-13-020065","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520813020065/doc4.xml","form_type":"4"}},{"id":474616,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Business Unit President"}}],"security":"Phantom Stock Units SSP","published_at":"2013-09-04T14:15:26.000Z","date":"2013-08-30","kind":"grant","acquired":true,"shares":64,"price":28.21,"value":1805.44,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":7915,"derivative":{"underlying":"Common Stock","underlying_shares":64},"source":{"system":"sec-edgar","filing":"0001225208-13-018980","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520813018980/doc4.xml","form_type":"4"}},{"id":475003,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Business Unit President"}}],"security":"Phantom Stock Units SSP","published_at":"2013-08-16T19:01:12.000Z","date":"2013-08-15","kind":"grant","acquired":true,"shares":63,"price":28.8,"value":1814.4,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":7851,"derivative":{"underlying":"Common Stock","underlying_shares":63},"source":{"system":"sec-edgar","filing":"0001225208-13-017992","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520813017992/doc4.xml","form_type":"4"}},{"id":475510,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Business Unit President"}}],"security":"Phantom Stock Units SSP","published_at":"2013-08-01T21:49:46.000Z","date":"2013-07-31","kind":"grant","acquired":true,"shares":124,"price":29.23,"value":3624.52,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":7788,"derivative":{"underlying":"Common Stock","underlying_shares":124},"source":{"system":"sec-edgar","filing":"0001225208-13-017087","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520813017087/doc4.xml","form_type":"4"}},{"id":475884,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Business Unit President"}}],"security":"Phantom Stock Units SSP","published_at":"2013-07-16T22:29:43.000Z","date":"2013-07-15","kind":"grant","acquired":true,"shares":58,"price":28.79,"value":1669.82,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":7664,"derivative":{"underlying":"Common Stock","underlying_shares":58},"source":{"system":"sec-edgar","filing":"0001225208-13-016252","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520813016252/doc4.xml","form_type":"4"}},{"id":476233,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Business Unit President"}}],"security":"Phantom Stock Units SSP","published_at":"2013-07-02T13:48:23.000Z","date":"2013-06-28","kind":"grant","acquired":true,"shares":65,"price":28.01,"value":1820.65,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":7606,"derivative":{"underlying":"Common Stock","underlying_shares":65},"source":{"system":"sec-edgar","filing":"0001225208-13-015230","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520813015230/doc4.xml","form_type":"4"}},{"id":476400,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Business Unit President"}}],"security":"Common Stock","published_at":"2013-06-29T01:26:39.000Z","date":"2013-06-26","kind":"other","acquired":false,"shares":233,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Rule 16b-3 Plan"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person disposed of 233 shares of Pfizer common stock in exchange for 228 shares of Zoetis Inc. Class A common stock within the Pfizer Savings and Investment Plan pursuant to a registered exchange offer to Pfizer shareholders commenced by Pfizer on May 22, 2013. The closing price of a share of Zoetis Inc. Class A common stock on the New York Stock Exchange on June 21, 2013, the trading day immediately preceding the day on which Pfizer accepted Pfizer shares that had been validly tendered and not validly withdrawn, was $30.60."}],"balance_after":731,"source":{"system":"sec-edgar","filing":"0001225208-13-014971","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520813014971/doc4.xml","form_type":"4"}},{"id":476412,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Business Unit President"}}],"security":"Common Stock","published_at":"2013-06-26T19:46:39.000Z","date":"2013-06-24","kind":"disposition_to_issuer","acquired":false,"shares":217,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Compensation Committee of the Board of Directors of Pfizer Inc. (Pfizer) has approved the disposition of these shares of Pfizer common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person disposed of 217 shares of Pfizer common stock in exchange for 214 shares of Zoetis Inc. Class A common stock (plus cash in lieu of a fractional share)  pursuant to a registered exchange offer to Pfizer shareholders commenced by Pfizer on May 22, 2013. The closing price of a share of Zoetis Inc. Class A common stock on the New York Stock Exchange on June 21, 2013, the trading day immediately preceding the day on which Pfizer accepted Pfizer shares that had been validly tendered and not validly withdrawn, was $30.60."}],"balance_after":226726,"source":{"system":"sec-edgar","filing":"0001225208-13-014872","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520813014872/doc4.xml","form_type":"4"}},{"id":476507,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Business Unit President"}}],"security":"Phantom Stock Units SSP","published_at":"2013-06-18T17:07:15.000Z","date":"2013-06-14","kind":"grant","acquired":true,"shares":55,"price":29.09,"value":1599.95,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":7541,"derivative":{"underlying":"Common Stock","underlying_shares":55},"source":{"system":"sec-edgar","filing":"0001225208-13-014500","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520813014500/doc4.xml","form_type":"4"}},{"id":476996,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Business Unit President"}}],"security":"Phantom Stock Units SSP","published_at":"2013-06-03T22:31:40.000Z","date":"2013-05-31","kind":"grant","acquired":true,"shares":71,"price":27.23,"value":1933.33,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":7486,"derivative":{"underlying":"Common Stock","underlying_shares":71},"source":{"system":"sec-edgar","filing":"0001225208-13-013702","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520813013702/doc4.xml","form_type":"4"}},{"id":477739,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Business Unit President"}}],"security":"Phantom Stock Units SSP","published_at":"2013-05-16T23:30:19.000Z","date":"2013-05-15","kind":"grant","acquired":true,"shares":117,"price":29.56,"value":3458.52,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":7415,"derivative":{"underlying":"Common Stock","underlying_shares":117},"source":{"system":"sec-edgar","filing":"0001225208-13-012565","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520813012565/doc4.xml","form_type":"4"}},{"id":478470,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Business Unit President"}}],"security":"Phantom Stock Units SSP","published_at":"2013-05-01T22:23:56.000Z","date":"2013-04-30","kind":"grant","acquired":true,"shares":61,"price":29.07,"value":1773.27,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":7298,"derivative":{"underlying":"Common Stock","underlying_shares":61},"source":{"system":"sec-edgar","filing":"0001225208-13-010916","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520813010916/doc4.xml","form_type":"4"}},{"id":478838,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Business Unit President"}}],"security":"Phantom Stock Units SSP","published_at":"2013-04-17T12:09:50.000Z","date":"2013-04-15","kind":"grant","acquired":true,"shares":53,"price":30.45,"value":1613.85,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":7237,"derivative":{"underlying":"Common Stock","underlying_shares":53},"source":{"system":"sec-edgar","filing":"0001225208-13-010055","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520813010055/doc4.xml","form_type":"4"}},{"id":479333,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Business Unit President"}}],"security":"Phantom Stock Units SSP","published_at":"2013-04-01T20:16:34.000Z","date":"2013-03-28","kind":"grant","acquired":true,"shares":57,"price":28.86,"value":1645.02,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":7184,"derivative":{"underlying":"Common Stock","underlying_shares":57},"source":{"system":"sec-edgar","filing":"0001225208-13-008773","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520813008773/doc4.xml","form_type":"4"}},{"id":479683,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Business Unit President"}}],"security":"Phantom Stock Units SSP","published_at":"2013-03-18T21:48:20.000Z","date":"2013-03-15","kind":"grant","acquired":true,"shares":1810,"price":28.02,"value":50716.2,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":7127,"derivative":{"underlying":"Common Stock","underlying_shares":1810},"source":{"system":"sec-edgar","filing":"0001225208-13-007873","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520813007873/doc4.xml","form_type":"4"}},{"id":479741,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Business Unit President"}}],"security":"Common Stock","published_at":"2013-03-14T21:54:50.000Z","date":"2013-03-14","kind":"sale","acquired":false,"shares":40000,"price":28,"value":1120000.0,"ownership":{"direct":true},"balance_after":224392,"source":{"system":"sec-edgar","filing":"0001225208-13-007709","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520813007709/doc4.xml","form_type":"4"}},{"id":480842,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Business Unit President"}}],"security":"Stock Appreciation Rights","published_at":"2013-03-05T00:02:09.000Z","date":"2013-02-28","kind":"grant","acquired":true,"shares":137112,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant."}],"balance_after":137112,"derivative":{"exercise_price":27.37,"exercise_date":"2020-02-28","expiration_date":"2020-02-28","underlying":"Common Stock","underlying_shares":137112},"source":{"system":"sec-edgar","filing":"0001225208-13-006460","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520813006460/doc4.xml","form_type":"4"}},{"id":480841,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Business Unit President"}}],"security":"Stock Appreciation Rights","published_at":"2013-03-05T00:02:09.000Z","date":"2013-02-28","kind":"grant","acquired":true,"shares":165198,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant."}],"balance_after":165198,"derivative":{"exercise_price":27.37,"exercise_date":"2018-02-28","expiration_date":"2018-02-28","underlying":"Common Stock","underlying_shares":165198},"source":{"system":"sec-edgar","filing":"0001225208-13-006460","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520813006460/doc4.xml","form_type":"4"}},{"id":480840,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Business Unit President"}}],"security":"Phantom Stock Units SSP","published_at":"2013-03-05T00:02:09.000Z","date":"2013-02-28","kind":"grant","acquired":true,"shares":12,"price":27.37,"value":328.44,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each unit represents one phantom share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":5317,"derivative":{"underlying":"Common Stock","underlying_shares":12},"source":{"system":"sec-edgar","filing":"0001225208-13-006460","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520813006460/doc4.xml","form_type":"4"}},{"id":480839,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Business Unit President"}}],"security":"Common Stock","published_at":"2013-03-05T00:02:09.000Z","date":"2013-02-28","kind":"tax_withholding","acquired":false,"shares":17341,"price":27.37,"value":474623.17,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon)."}],"balance_after":264392,"source":{"system":"sec-edgar","filing":"0001225208-13-006460","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520813006460/doc4.xml","form_type":"4"}},{"id":480838,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Business Unit President"}}],"security":"Common Stock","published_at":"2013-03-05T00:02:09.000Z","date":"2013-02-28","kind":"grant","acquired":true,"shares":27943,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements."}],"balance_after":281733,"source":{"system":"sec-edgar","filing":"0001225208-13-006460","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520813006460/doc4.xml","form_type":"4"}},{"id":480837,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Business Unit President"}}],"security":"Common Stock","published_at":"2013-03-05T00:02:09.000Z","date":"2013-02-28","kind":"grant","acquired":true,"shares":35946,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon)."}],"balance_after":253790,"source":{"system":"sec-edgar","filing":"0001225208-13-006460","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520813006460/doc4.xml","form_type":"4"}},{"id":484236,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Business Unit President"}}],"security":"Phantom Stock Units SSP","published_at":"2013-01-02T23:06:50.000Z","date":"2012-12-28","kind":"grant","acquired":true,"shares":73,"price":24.89,"value":1816.97,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":5264,"derivative":{"underlying":"Common Stock","underlying_shares":73},"source":{"system":"sec-edgar","filing":"0001225208-13-000256","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520813000256/doc4.xml","form_type":"4"}},{"id":484728,"issuer":{"id":2863,"kind":"organization","name":"PFIZER INC","symbol":"PFE"},"owners":[{"id":16443,"kind":"person","name":"Germano Geno J","position":1,"cik":"0001424383","reported_name":"Germano Geno J","relationship":{"officer":true,"officer_title":"Business Unit President"}}],"security":"Phantom Stock Units SSP","published_at":"2012-12-17T23:32:29.000Z","date":"2012-12-14","kind":"grant","acquired":true,"shares":62,"price":25.18,"value":1561.16,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each unit represents one phantom share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time."}],"balance_after":5191,"derivative":{"underlying":"Common Stock","underlying_shares":62},"source":{"system":"sec-edgar","filing":"0001225208-12-025449","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/78003/000122520812025449/doc4.xml","form_type":"4"}}],"next_cursor":"2012-12-17T23:32:29.000000Z,484728"}